or Try an Advanced Search...

    Technical Analysis for AUTL - Autolus Therapeutics plc

    Grade Last Price % Change Price Change
    F 3.47 -0.29% -0.01
    AUTL closed down 0.29 percent on Monday, July 1, 2024, on 36 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AUTL trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Bullish Engulfing Bullish -0.29%
    Lower Bollinger Band Walk Weakness -0.29%
    Earnings Movers Other -0.29%
    Outside Day Range Expansion -0.29%
    Older End-of-Day Signals for AUTL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    Down 3% about 10 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AUTL Chart by TradingView
    Basic chart:

    Profile

    Autolus Therapeutics Ltd is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Treatment Of Cancer

    Is AUTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 13 Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
    May 31 Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
    May 18 Q1 2024 Autolus Therapeutics PLC Earnings Call
    May 17 Autolus Therapeutics plc (AUTL) Q1 2024 Earnings Call Transcript
    May 17 Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
    May 17 Autolus Therapeutics GAAP EPS of -$0.24 misses by $0.09, revenue of $10.09M misses by $14.96M
    May 17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
    May 14 Autolus Therapeutics: Trading Like Their Products Are Not Valuable, Which Is An Opportunity
    May 14 Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
    May 13 Autolus Therapeutics Q1 2024 Earnings Preview
    See more AUTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.45
    52 Week Low 2.01
    Average Volume 1,769,980
    200-Day Moving Average 4.64
    50-Day Moving Average 4.04
    20-Day Moving Average 3.99
    10-Day Moving Average 3.67
    Average True Range 0.28
    RSI (14) 36.31
    ADX 15.79
    +DI 18.35
    -DI 24.29
    Chandelier Exit (Long, 3 ATRs) 3.93
    Chandelier Exit (Short, 3 ATRs) 3.97
    Upper Bollinger Bands 4.77
    Lower Bollinger Band 3.20
    Percent B (%b) 0.17
    BandWidth 39.52
    MACD Line -0.21
    MACD Signal Line -0.14
    MACD Histogram -0.0707
    Fundamentals Value
    Market Cap 603.74 Million
    Num Shares 174 Million
    EPS -0.98
    Price-to-Earnings (P/E) Ratio -3.54
    Price-to-Sales 200.99
    Price-to-Book 6.15
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.74
    Resistance 3 (R3) 3.74 3.64 3.70
    Resistance 2 (R2) 3.64 3.57 3.65 3.68
    Resistance 1 (R1) 3.56 3.53 3.60 3.56 3.67
    Pivot Point 3.46 3.46 3.49 3.47 3.46
    Support 1 (S1) 3.38 3.39 3.42 3.38 3.27
    Support 2 (S2) 3.28 3.35 3.28 3.26
    Support 3 (S3) 3.20 3.28 3.24
    Support 4 (S4) 3.20